ImmunityBio (IBRX)
NASDAQ:IBRX
Want to see IBRX full AI Analyst Report?
ImmunityBio (IBRX) Ownership Overview
64.09% Insiders
3.91% Mutual Funds
0.59% Other Institutional Investors
6.30% ETFs
25.11% Public Companies and Individual Investors
The ownership structure of ImmunityBio (IBRX) stock is a mix of institutional, retail, and individual investors. Approximately 10.80% of the company’s stock is owned by Institutional Investors, 64.09% is owned by Insiders, and 25.11% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 02, 2026 | xxxxxxxxxxxxx | $24967750 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2023 | xxxxxxxxxxxxx | $83423 | |
Dec 31, 2023 | xxxxxxxxxxxxx | $6824149 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 654,612,336 | Insider | 63.67% | 4,863,769,656 | |
| 30,765,592 | Institution | 2.99% | 228,588,349 | |
| 27,196,622 | Institution | 2.65% | 202,070,901 | |
| 15,673,076 | Institution | 1.52% | 116,450,955 | |
| 11,751,126 | Institution | 1.14% | 87,310,866 | |
| 3,451,428 | Institution | 0.34% | 25,644,110 | |
| 3,446,540 | Institution | 0.34% | 25,607,792 | |
| 3,133,118 | Institution | 0.30% | 23,279,067 | |
| 2,850,821 | Insider | 0.28% | 21,181,600 | |
| 1,747,009 | Institution | 0.17% | 12,980,277 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 27,196,622 | Institution | 2.65% | 202,070,901 | |
| 3,451,428 | Institution | 0.34% | 25,644,110 | |
| 3,133,118 | Institution | 0.30% | 23,279,067 | |
| 1,747,009 | Institution | 0.17% | 12,980,277 | |
| 995,597 | Institution | 0.10% | 7,397,286 | |
| 886,389 | Institution | 0.09% | 6,585,870 | |
| 881,772 | Institution | 0.09% | 6,551,566 | |
| 465,000 | Institution | 0.05% | 3,454,950 | |
| 233,398 | Institution | 0.02% | 1,734,147 | |
| 198,975 | Institution | 0.02% | 1,478,384 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,349,072 | Institution | 1.10% | 87,047,382 | |
| 11,159,782 | Institution | 1.09% | 82,917,180 | |
| 8,298,477 | Institution | 0.81% | 63,649,319 | |
| 7,088,309 | Institution | 0.69% | 52,666,136 | |
| 4,639,947 | Institution | 0.45% | 35,588,393 | |
| 3,410,327 | Institution | 0.33% | 26,157,208 | |
| 2,557,167 | Institution | 0.25% | 18,999,751 | |
| 1,996,918 | Institution | 0.19% | 14,837,101 | |
| 1,491,296 | Institution | 0.15% | 11,080,329 | |
| 1,452,841 | Institution | 0.14% | 11,143,290 |
FAQ
Who Owns ImmunityBio (IBRX)?
According to the latest TipRanks data, approximately 0.59% of the company's stock is held by institutional investors, 64.09% is held by insiders, and 25.11% is held by retail investors.
What percentage of ImmunityBio (IBRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.59% of ImmunityBio (IBRX) stock is held by institutional investors.
What percentage of ImmunityBio (IBRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 25.11% of ImmunityBio (IBRX) stock is held by retail investors.
Who owns the most shares of ImmunityBio (IBRX)?
Shiong Patrick Soon owns the most shares of ImmunityBio (IBRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.